Johnson & Johnson has announced that it has paused coronavirus vaccine trials after a participant developed an “unexplained illness.” STAT reported that the company was running a 60,000-patient clinical trial for a COVID-19 vaccine, but they sent out a document stating a “pausing rule.” Johnson & Johnson confirmed to the outlet that the trials are on pause because of “an unexplained illness in a study participant.” “We must respect this participant’s privacy.
We’re also learning more about this participant’s illness, and it’s important to have all the facts before we share additional information,” the company said in a statement.